港股早評:三大指數大幅低開 科技股普跌 配售425億港元小米大跌5.5%
隔夜美股三大指數小幅收漲,中概指數跌1.73%。港股三大指數大幅低開,恆指跌1.1%,國指跌1.27%,恆生科技指數跌1.71%。盤面上,大型科技股全線下跌,其中,折價6.5%配售425億港元,小米大跌5.5%,美團、阿里巴巴、快手跌1.6%,京東、百度跌0.6%;DeepSeek概念股普遍弱勢,金山雲跌超4%,萬國數據、嗶哩嗶哩、金蝶國際、微盟集團均下跌;重型機械股、汽車股、蘋果概念股、內險股、內銀股紛紛走低,中聯重科績後跌4.6%,小鵬汽車跌超4%。另一方面,機器人概念股部分繼續上漲,昨日創新高的盛業續漲3.57%,體育用品股、航空股、濠賭股多數上漲,中國國航、美高梅中國漲近2%。(格隆匯)
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.